UNSPSC 51281704: Aspoxicillin

This classification denotes a penicillin antibiotic with the molecular formula C21H27N5O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0745KNO26J, chemically known as glycinamide, n-methyl-d-asparaginyl-n-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-d-2-(4-hydroxyphenyl)-, (2s-(2-alpha,5-alpha,6-beta))- but generally known as aspoxicillin, which bears US NIH Compound Identifier 71961.

UNSPSC 51281704 Aspoxicillin, a Commodity code, shows activity focused on pharmaceutical procurement by state health agencies, counties, and municipalities acquiring medical supplies, naloxone, and generic pharmaceuticals for public health and emergency response programs. The recent solicitations under this code reveal state and local governments buying naloxone and drug deactivation systems for community health initiatives, medical and first aid supplies for fire and rescue operations, and participating in cooperative purchasing agreements for generic multi-source pharmaceuticals and over-the-counter products distributed across government facilities. Issuing bodies include county health departments (Seminole County, Florida), city fire departments (City of Tampa), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The mix reflects both single-jurisdiction procurements and regional or multi-state cooperative purchasing vehicles that aggregate demand across multiple jurisdictions.

Recent activity concentrates in Florida, Texas, and Minnesota, with secondary participation from Oregon through MMCAP's multistate agreement. Representative solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, due July 26, 2023; the City of Tampa's invitation to bid (ITB 26-P-00145) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with a $700,000 estimated contract value and a 5 percent bid discount for certified Small Local Business Enterprises, due March 13, 2026; the Texas Health and Human Services Commission's Request for Information (RFI HHS0017013) for direct-to-manufacturer prescription program capabilities, posted April 3, 2026; and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products through authorized wholesalers with proposals due March 26, 2026, and award effective July 1, 2026. The Tampa and MMCAP procurements carry set-aside or preference provisions—Tampa explicitly sheltered its bid to certified SLBEs, while MMCAP reserves multi-award discretion based on therapeutic and member-specific needs across participating jurisdictions.